Resistance on Antithrombotic Drugs in Ischemic Heart Disease
NCT ID: NCT00742430
Last Updated: 2012-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
141 participants
OBSERVATIONAL
2009-02-28
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531
Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance
NCT00697021
Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
NCT00508924
Prospective Real-world Registry Describing Treatment Regimens
NCT03942913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Resistant
patients who are resistant to standard antithrombotic drugs
PCI
percutaneous coronary intervention in stable coronary artery disease
Nonresistant
patients who are not resistant to standard dual antithrombotic drugs
PCI
percutaneous coronary intervention in stable coronary artery disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PCI
percutaneous coronary intervention in stable coronary artery disease
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 7 days on aspirin 100mg therapy before the intervention
* \> 7 days on clopidogrel 75mg therapy before the intervention
Exclusion Criteria
* \< 7 days on aspirin therapy before the intervention
* Myocardial infarction less than 30 days before the intervention
* Cerebrovascular incident less that three months before the intervention
* Haemorrhagic diathesis
* Trc \< 100
* Htc \< 30%
* Creatinine \> 140
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zagreb
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Davor Milicic
prof. dr. sc. F.E.S.C.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Davor Milicic, prof.dr.sc.
Role: PRINCIPAL_INVESTIGATOR
Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro, Zagreb, Croatia
Bosko Skoric, dr.
Role: STUDY_CHAIR
Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro, Zagreb, Croatia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
108-1081875-1993
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.